Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
Benchmarking
Randomized Controlled Trial of Benchmarking to Reduce Bronchopulmonary Dysplasia to Reduce Bronchopulmonary Dysplasia
24 other identifiers
interventional
4,095
1 country
17
Brief Summary
This study tested whether Neonatal Intensive Care Unit (NICU) teams trained in benchmarking -- comparing care practices between different NICUs to see which practices prevent bronchopulmonary dysplasia (BPD) -- and quality improvement would change practices and improve rates of survival without BPD in inborn neonates with birth weights of \<1250 grams. Benchmarking is a method involving detailed comparisons of processes between similar organizations. For this study, three NRN centers with the lowest rates of BPD have been identified as Benchmark centers. During a 6-month pre-intervention period, details of care practices and management style at these centers were carefully assessed. Based on practices at these Benchmarking sites, we developed a quality improvement program. For this study, 14 other NRN sites were randomized to either implement the benchmarking intervention (intervention sites) or continue with their usual care practices (control sites). After the 1-year intervention period, we compared changes in the rate of survival without BPD at 36 weeks corrected age between the intervention and control sites.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2001
Longer than P75 for not_applicable
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2001
CompletedFirst Submitted
Initial submission to the registry
August 25, 2003
CompletedFirst Posted
Study publicly available on registry
August 26, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2004
CompletedJune 8, 2015
June 1, 2015
3.2 years
August 25, 2003
June 3, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival without BPD
36 weeks of life
Secondary Outcomes (1)
Bronchopulmonary Dysplasia
36 weeks of life
Study Arms (2)
Intervention
ACTIVE COMPARATORClinical sites randomized to intervention will receive training in the benchmarking BPD management methods identified at the Benchmark sites.
Control
PLACEBO COMPARATORClinical sites randomized to Control will continue with their normal management practices for BPD.
Interventions
The Benchmarking intervention included: 1. Data feedback: Using existing data from the NRN Generic Database and Key Care Practices Survey at their NICU to collect data on the perceptions of care. 2. Training in Continuous Quality Improvement (CQI) Techniques 3. Review of best existing evidence 4. Site visits to the Centers with the Lowest Rates of BPD 5. Selection of Practices to change: Each site team selected practices for modification at their own center
Centers assigned to the control group continued to receive routine information on their own center's outcomes, and all information routinely supplied within the NRN. Control centers did not participate in organized discussions of the interventions applied within the Benchmarking centers. At the completion of the study, Control Centers were offered a workshop on the Benchmarking techniques.
Eligibility Criteria
You may qualify if:
- Infants 501-1,249g birthweight
- Registered in a participating site
You may not qualify if:
- Diagnosed with a syndrome as defined by the Neonatal Research Network's Generic Database Study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (17)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
Stanford University
Palo Alto, California, 94304, United States
University of California at San Diego
San Diego, California, 92103-8774, United States
Yale University
New Haven, Connecticut, 06504, United States
University of Miami
Miami, Florida, 33136, United States
Emory University
Atlanta, Georgia, 30303, United States
Indiana University
Indianapolis, Indiana, 46202, United States
Wayne State University
Detroit, Michigan, 48201, United States
University of Rochester
Rochester, New York, 14642, United States
Wake Forest University
Charlotte, North Carolina, 27157, United States
RTI International
Durham, North Carolina, 27705, United States
Duke University
Durham, North Carolina, 27710, United States
Cincinnati Children's Medical Center
Cincinnati, Ohio, 45267, United States
Case Western Reserve University, Rainbow Babies and Children's Hospital
Cleveland, Ohio, 44106, United States
Brown University, Women & Infants Hospital of Rhode Island
Providence, Rhode Island, 02905, United States
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, 75235, United States
University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Related Publications (6)
Bhandari V, Finer NN, Ehrenkranz RA, Saha S, Das A, Walsh MC, Engle WA, VanMeurs KP; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Synchronized nasal intermittent positive-pressure ventilation and neonatal outcomes. Pediatrics. 2009 Aug;124(2):517-26. doi: 10.1542/peds.2008-1302. Epub 2009 Jul 27.
PMID: 19651577RESULTLaptook AR, Salhab W, Allen J, Saha S, Walsh M. Pulse oximetry in very low birth weight infants: can oxygen saturation be maintained in the desired range? J Perinatol. 2006 Jun;26(6):337-41. doi: 10.1038/sj.jp.7211500.
PMID: 16598294RESULTShankaran S, Langer JC, Kazzi SN, Laptook AR, Walsh M; National Institute of Child Health and Human Development Neonatal Research Network. Cumulative index of exposure to hypocarbia and hyperoxia as risk factors for periventricular leukomalacia in low birth weight infants. Pediatrics. 2006 Oct;118(4):1654-9. doi: 10.1542/peds.2005-2463.
PMID: 17015558RESULTWalsh M, Laptook A, Kazzi SN, Engle WA, Yao Q, Rasmussen M, Buchter S, Heldt G, Rhine W, Higgins R, Poole K; National Institute of Child Health and Human Development Neonatal Research Network. A cluster-randomized trial of benchmarking and multimodal quality improvement to improve rates of survival free of bronchopulmonary dysplasia for infants with birth weights of less than 1250 grams. Pediatrics. 2007 May;119(5):876-90. doi: 10.1542/peds.2006-2656.
PMID: 17473087RESULTWalsh M, Engle W, Laptook A, Kazzi SN, Buchter S, Rasmussen M, Yao Q; National Institute of Child Health and Human Development Neonatal Research Network. Oxygen delivery through nasal cannulae to preterm infants: can practice be improved? Pediatrics. 2005 Oct;116(4):857-61. doi: 10.1542/peds.2004-2411.
PMID: 16199694RESULTWilson-Costello D, Walsh MC, Langer JC, Guillet R, Laptook AR, Stoll BJ, Shankaran S, Finer NN, Van Meurs KP, Engle WA, Das A; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Pediatrics. 2009 Mar;123(3):e430-7. doi: 10.1542/peds.2008-1928. Epub 2009 Feb 9.
PMID: 19204058RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Michele C. Walsh, MD
Case Western Reserve University, Rainbow Babies & Children's Hospital
- PRINCIPAL INVESTIGATOR
William Oh, MD
Brown University, Women & Infants Hospital of Rhode Island
- PRINCIPAL INVESTIGATOR
Waldemar A. Carlo, MD
University of Alabama at Birmingham
- PRINCIPAL INVESTIGATOR
Shahnaz Duara, MD
University of Miami
- PRINCIPAL INVESTIGATOR
Barbara J. Stoll, MD
Emory University
- PRINCIPAL INVESTIGATOR
James A. Lemons, MD
Indiana University
- PRINCIPAL INVESTIGATOR
David K. Stevenson, MD
Stanford University
- PRINCIPAL INVESTIGATOR
Neil N. Finer, MD
University of California, San Diego
- PRINCIPAL INVESTIGATOR
Abbot R. Laptook, MD
University of Texas Southwestern Medical Center
- PRINCIPAL INVESTIGATOR
Seetha Shankaran, MD
Wayne State University
- PRINCIPAL INVESTIGATOR
Edward F. Donovan, MD
Children's Hospital Medical Center, Cincinnati
- PRINCIPAL INVESTIGATOR
Ronald N. Goldberg, MD
Duke University
- PRINCIPAL INVESTIGATOR
Dale L. Phelps, MD
University of Rochester
- PRINCIPAL INVESTIGATOR
Jon E. Tyson, MD MPH
The University of Texas Health Science Center, Houston
- PRINCIPAL INVESTIGATOR
T. Michael O'Shea, MD MPH
Wake Forest University
- PRINCIPAL INVESTIGATOR
Richard A. Ehrenkranz, MD
Yale University
- PRINCIPAL INVESTIGATOR
W. Kenneth Poole, PhD
RTI International
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
Study Record Dates
First Submitted
August 25, 2003
First Posted
August 26, 2003
Study Start
March 1, 2001
Primary Completion
May 1, 2004
Study Completion
May 1, 2004
Last Updated
June 8, 2015
Record last verified: 2015-06